tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Greg Harrison, 45 are a BUY (70.31%), 14 are a HOLD (21.88%), 5 are a SELL (7.81%).
Analyst Greg Harrison, currently employed at SCOTIABANK, carries an average stock price target met ratio of 62.22% that have a potential upside of 42.6% achieved within 124 days. Previously, Greg Harrison worked at BAML.
Greg Harrison’s has documented 121 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BBIO, BridgeBio Pharma at 15-Nov-2024.
Analyst best performing recommendations are on OMER (OMEROS).
The best stock recommendation documented was for OMER (OMEROS) at 11/8/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.2 (6.25%) receiving and performance score of 62.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$6.25
$6.24 (62400.00%)
$25
2 years 5 months 30 days ago
(23-May-2022)
1/3 (33.33%)
$0.9 (16.82%)
14
Buy
$11
3 years 9 months 5 days ago
(17-Feb-2021)
1/1 (100%)
$-23.25 (-67.88%)
998
Buy
$125
$124.57 (28969.77%)
4 years 6 months 14 days ago
(08-May-2020)
0/1 (0%)
$54 (76.06%)
Which stock is Greg Harrison is most bullish on?
Which stock is Greg Harrison is most reserved on?
What Year was the first public recommendation made by Greg Harrison?
